HORIZON-JU-GH-EDCTP3-2024-01-01-two-stage
HORIZON-JU-GH-EDCTP3-2024-01-01-two-stage
Programme: Horizon Europe
4 projects · €23,412,255 total EU contribution (project-level) · 43 participating organizations · 15 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€23,412,255
Countries active
Participant organizations by country (headquarters in CORDIS).
- France (5)
- UK (5)
- ZA (5)
- Spain (4)
- MZ (4)
- UG (4)
- Italy (3)
- CM (2)
- KE (2)
- Netherlands (2)
- US (2)
- ZW (2)
- BR (1)
- CI (1)
- TH (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- PACCI2 projects · CI
- FONDAZIONE PENTA ETS2 projects · IT
- INSERM2 projects · FR
- RADBOUDUMC2 projects · NL
- UEM2 projects · MZ
- University of Zimbabwe2 projects · ZW
- ADERA1 projects · FR
- AFRICA HEALTH RESEARCH INSTITUTE (AHRI)1 projects · ZA
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1 projects · FR
- BAYLOR COLLEGE OF MEDICINE CHILDRENS FOUNDATION UGANDA LTD1 projects · UG
- CENTRE FOR SEXUAL HEALTH AND HIV AND AIDS RESEARCH1 projects · ZW
- CPC1 projects · CM
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
EARLY NEUTRALIZING ANTIBODIES IN INFANTS LIVING WITH HIV TO ENHANCE THEIR LIFE ENABLE · 101190620 | HORIZON | €6,161,158 | €575,633 | Details |
Toxicity of dolutegravir and evaluation of doravirine for alternative 1st line antiretroviral treatment in people living with HIV ELDORADO · 101190925 | HORIZON | €5,164,865 | €378,204 | Details |
CHAPAS-5: An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in ART-naive and Treatment-experienced Viraemic Children and Adolescents Living with HIV in Africa CHAPAS-5 · 101190645 | HORIZON | €6,587,149 | €2,245,464 | Details |
Pragmatic use of long-acting Oral Antiretrovirals in Africa POA · 101190884 | HORIZON | €5,499,083 | €700,000 | Details |